Related Experiment Videos
Melatonin administration prevents the nephrotoxicity induced by gentamicin
1Departments of Urology, Biochemistry, Pharmacology and Pathology, Inonu University School of Medicine, Malatya, Turkey. eozbek@superonline.com
BJU International
|April 12, 2000
Summary
Melatonin effectively prevents gentamicin-induced kidney damage in rats by acting as an antioxidant and restoring vital enzyme activity. This study highlights melatonin
Area of Science:
- Nephrology
- Pharmacology
- Biochemistry
Background:
- Gentamicin is a common antibiotic with known nephrotoxic side effects.
- Oxidative stress plays a significant role in gentamicin-induced kidney injury.
- Antioxidants may offer a protective strategy against drug-induced nephrotoxicity.
Purpose of the Study:
- To evaluate the protective effects of melatonin against gentamicin-induced renal tubular necrosis.
- To assess the impact of melatonin on antioxidant enzyme activity in the rat kidney.
Main Methods:
- Adult male Sprague-Dawley rats were divided into control, gentamicin-only, and gentamicin plus melatonin groups.
- Kidney tissue and blood/urine samples were analyzed for markers of damage and oxidative stress.
- Histological examination assessed the extent of tubular necrosis.
Main Results:
- Gentamicin induced significant renal tubular necrosis, increased lipoperoxides, and decreased antioxidant enzyme activity (GSH-Px, catalase, SOD).
- Melatonin treatment markedly reduced tubular damage and restored antioxidant enzyme levels and lipid peroxidation.
- Melatonin also mitigated gentamicin-induced increases in serum gamma-GT and proteinuria.
Conclusions:
- Melatonin demonstrates a significant protective effect against gentamicin-induced nephrotoxicity in rats.
- Melatonin's antioxidant properties and ability to restore antioxidant enzyme activity are key to its renoprotective effects.